glp 1 agonist parkinson GLP-1 Signalling as a Therapeutic Avenue in Parkinson's Disease: A Comprehensive Review Are GLP-1 diabetes drugs like
Description
The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults With Type 2 Diabetes
At the 1mg dose, roughly 14% of participants reported nausea
We used SGLT-2 inhibitors as active comparators
Front Endocrinol (Lausanne) (2014) 5:140
10.1001/jamainternmed.2022.0338 JAMA Intern Med
